Preprint
Article

This version is not peer-reviewed.

Outcome of Post-Stroke Rehabilitation in Nonagenarians

Submitted:

17 April 2026

Posted:

20 April 2026

You are already at the latest version

Abstract
Objective: To compare rehabilitation outcomes in nonagenarian stroke patients (≥90 years) with those of younger elderly patients (65–89 years). Design: Retrospective parallel-group study. Setting: Geriatric rehabilitation department in an urban academic hospital. Participants: Medical records of 906 consecutive elderly patients admitted for post-stroke neurorehabilitation between 2015 and 2019 were reviewed. After exclusions, 876 patients were included. Main Outcome Measure: Discharge destination (home vs. long-term care facility). Results: Of the 876 patients, 803 were aged 65–89 years and 73 were aged ≥90 years. Median admission FIM scores were 54 and 46, respectively. Median FIM improvement (ΔFIM) was 16 in the younger group and 11 in the ≥90 group (p< 0.01). Median length of stay was similar (41 vs. 40 days; p=0.93). Discharge home rates were comparable (78.2% vs. 76.7%; p=0.776). Conclusions: Nonagenarian stroke patients benefit meaningfully from inpatient rehabilitation, achieving substantial functional gains and community discharge rates comparable to younger elderly patients.
Keywords: 
;  ;  ;  

1. Introduction

Stroke incidence increases markedly with advancing age, with approximately half of all strokes occurring in individuals over 75 years and nearly one-third in those over 85 years [1,2,3]. Stroke remains a leading cause of long-term disability and reduced quality of life among older adults [4].
Age has consistently been identified as a predictor of functional outcome, mortality, length of hospitalization, and institutionalization after stroke [5,6,7,8]. However, it remains unclear to what extent poor outcomes are attributable to age per se versus comorbidities, baseline functional status, and medical complications.
Importantly, many stroke rehabilitation trials underrepresent the oldest old. A review of studies included in the Cochrane Database demonstrated that the mean age of participants was nearly a decade younger than the typical stroke population encountered in clinical practice. Furthermore, many trials excluded patients with cognitive impairment, aphasia, or recurrent strokes—characteristics common among very elderly individuals.
Some studies report reduced rehabilitation efficacy among the oldest old [6,8,10,11,12], whereas others suggest that chronological age alone does not independently predict poor rehabilitation outcome [13,14].
A large community-based cohort study in Denmark (191 over 85 years) reported that more than 58% of the very elderly (85 years old and above) were discharged to nursing homes or died during hospital stay post stroke [15]. In a multicenter prospective cohort study of over 300 patients of at least 75 years of age with a first stroke, age was both significantly related to low Functional Independence Measure (FIM) score upon discharge and independently and inversely related to rehabilitation efficacy (Montebello Rehabilitation Factor Score) [16].
Given demographic aging and the growing proportion of nonagenarians (individuals 90-99 years) worldwide, understanding rehabilitation outcomes in this age group is of substantial clinical relevance. The present study aimed to compare functional recovery and discharge destination in patients aged ≥90 years with those aged 65–89 years.

2. Methods

2.1. Study Design and Ethics

This retrospective study was approved by the institutional ethics committee of Kaplan Medical Center, Rehovot, Israel, with the protocol number: 0204-19-KMC.

2.2. Population

Medical records of all post-stroke patients admitted to Herzfeld Geriatric Rehabilitation Hospital between January 1, 2015, and December 31, 2019, were reviewed.
Inclusion criteria: Age ≥65 years, diagnosis of ischemic or hemorrhagic stroke confirmed by CT or MRI, admission to inpatient rehabilitation.
Exclusion criteria: length of stay ≤7 days or in-hospital death.
Patients were categorized into two groups: 65–89 years and ≥90 years.

2.3. Outcome Measures

The primary outcome was discharge destination (home vs. long-term care facility).
Secondary outcomes included: FIM score at admission, FIM score at discharge, FIM gain (ΔFIM), length of stay and rehabilitation complications.

2.4. Statistical Analysis

Categorical and Nominal variables were reported by prevalence and percentages.
Categorical and Nominal variables were analyzed by Pearson's chi-square (χ²) for the relationship between two categorical variables.
Data are presented as means/median ± standard deviations or percentages.
Continuous variables between the various study groups were tested for normality by the Shapiro-Wilk test and when abnormal distribution was found, non-parametric tests were performed. The Mann-Whitney test was performed to compare two groups.
P value <0.05 was considered statistically significant. Data were analyzed using SPSS25.
The statistical analysis included: categorical variables with two values, Fisher's exact test; when there were more than two values, the Pearson's chi-squared test was used. For continuous and normally distributed variables, the t-test was used. The data are presented as mean and standard deviation. When the variables are continuous but not normally distributed, the Mann-Whitney test was used, and the values are presented as a median and the quarterly range. Normal distribution was examined by the Shapiro-Wilk test and the Kolmogorov-Smirnov test and by examining the scattering index of the distributions and normal Q-Q plots. The statistical analysis was performed in R software (R x64 4.0.2)

3. Results

A total of 906 patients were screened; 30 were excluded (9 deaths, 21 short stays), leaving 876 patients for analysis. Seventy-three patients (8.3%) were aged ≥90 years. Data were collected in a computer-based registry that included subjects aged 65 years and older with a diagnosis of ischemic or hemorrhagic stroke accident, confirmed by neuroimaging (computed tomography, CT, or Magnetic Resonance, MR) and classified according to Bamford criteria [18].
Baseline characteristics are presented in Table 1.
Nonagenarians had:
Lower prevalence of diabetes and hyperlipidemia
Higher prevalence of dementia
Similar rates of hypertension, coronary artery disease, heart failure, and chronic kidney disease
Stroke subtype and neurological deficits did not differ significantly between groups.
Rehabilitation Outcomes and Complications (Table 2)
Length of stay did not differ significantly (41 vs. 40 days).
Infections (pneumonia, urinary tract infections) were more common in nonagenarians. Urinary catheter use at discharge and constipation were also more frequent in the ≥90 group.
Admission FIM, discharge FIM, and ΔFIM were all significantly higher in the younger group. However, discharge to home was comparable between groups (78.2% vs. 76.7%).
Predictors of Discharge Home (Table 3)
In the 65–89 group, higher admission FIM predicted discharge home. Pneumonia, aphasia, atrial fibrillation, constipation, and urinary catheter at discharge were negatively associated with home discharge.
In the ≥90 group, no independent predictor of discharge destination reached statistical significance.

4. Discussion

The present study demonstrates that patients aged 90 years and older derive meaningful benefit from post-stroke rehabilitation, achieving functional improvement and discharge outcomes comparable to those of younger elderly patients. Although nonagenarians were admitted with lower baseline functional status and achieved smaller absolute gains in FIM scores, the proportion discharged home did not differ significantly between age groups. These findings challenge the common perception that very advanced age alone predicts poor rehabilitation outcomes.
Population-based data from North America and Europe demonstrate a steep age-related increase in long-term care residency. In the United States, approximately 1% of individuals aged 65–74 reside in nursing homes, increasing to 3% at ages 75–84 and approximately 8% among those aged 85 years and older [19]. Similarly, in England and Wales, 10.8% of individuals aged ≥85 years live in care homes [20]. Canadian census data report even higher proportions among the oldest old, with nearly 30% of those aged ≥85 residing in special care facilities [21]. These epidemiological trends underscore the substantial baseline risk of institutionalization in very elderly populations and highlight the clinical relevance of rehabilitation strategies that facilitate discharge to the community.
Against this background, the comparable home-discharge rates observed in our cohort (76.7% in ≥90 years vs. 78.2% in younger elderly patients) are particularly noteworthy. Despite lower admission FIM scores and higher rates of dementia, infections, urinary catheter use, and constipation, nonagenarians were not more likely to require long-term institutional placement. This finding suggests that chronological age alone should not be considered a limiting factor when allocating rehabilitation resources.
In both groups—nonagenarians and younger elderly patients—the median number of prescribed medications exceeded five, consistent with polypharmacy, and no significant difference was observed between the groups. This finding is noteworthy given the distinct morbidity profiles: nonagenarians demonstrated a higher prevalence of dementia, a lower prevalence of diabetes, and lower Functional Independence Measure (FIM) scores.
The high prevalence of polypharmacy aligns with the well-established association between multimorbidity, functional impairment, and increased healthcare utilization in geriatric populations [22,23,24]. Importantly, polypharmacy substantially elevates the risk of clinically significant drug–drug interactions (DDIs), a concern that is particularly relevant in older adults. Age-related alterations in pharmacokinetics and pharmacodynamics, diminished renal and hepatic reserve, and increased frailty further amplify susceptibility to adverse drug events [25,26,27,28]. Several medication classes that are more frequently prescribed in older adults, including antipsychotics [29], opioids [30] and monoclonal antibody therapies[31], carry considerable interaction potential and safety concerns. Previous studies have demonstrated that the risk of adverse drug reactions increases exponentially with the number of medications prescribed [32], with DDIs representing a major and potentially preventable cause of hospitalization in older adults [33].
The absence of significant differences in both polypharmacy prevalence and discharge destination between the two age groups—despite their differing morbidity profiles—is intriguing. This observation warrants further investigation in prospective, multicenter studies to better elucidate the underlying mechanisms and clinical implications.
Consistent with previous reports, in our work, younger elderly participants demonstrated higher FIM scores at admission and discharge and greater absolute functional gains [18,34]. However, the length of stay was nearly identical between groups (41 vs. 40 days), indicating comparable rehabilitation efficiency. The absence of prolonged hospitalization in the oldest group suggests that rehabilitation intensity and duration need not differ solely with age.
In the present work, multivariable analyses revealed that in the 65–89-year group, higher admission FIM predicted discharge home, whereas pneumonia, aphasia, atrial fibrillation, constipation during rehabilitation, and urinary catheter at discharge were negatively associated with community discharge. These findings are in line with prior literature identifying medical complications and reduced baseline function as principal determinants of institutionalization [17,18,34]. Interestingly, no independent prognostic factor was identified in the ≥90-year group. This may reflect pre-existing adaptation to functional limitations in very elderly individuals and their families, including established caregiving arrangements and environmental adjustments before the index stroke.
In our study, discharge destination was selected as the primary outcome measure because it represents a clinically meaningful endpoint with substantial implications for quality of life, caregiver burden, and healthcare expenditure. Given the high baseline prevalence of institutional residence among individuals aged ≥85 in Western countries, the ability to return nonagenarian stroke survivors to the community carries both humanitarian and economic significance.
This study has several limitations. Its retrospective, single-center design limits causal inference and may reduce generalizability to other healthcare settings. Important factors such as frailty, caregiver support, and pre-stroke functional trajectory were not systematically assessed and may have influenced discharge outcomes. The relatively small number of nonagenarians (n=73) limits statistical power, particularly in multivariable analyses, and may explain the absence of independent predictors in this subgroup. In addition, discharge destination, although clinically meaningful, does not capture long-term functional sustainability, quality of life, or post-discharge mortality. Finally, while medication burden was reported, a detailed assessment of potentially inappropriate medications and drug–drug interactions was not performed. Prospective studies incorporating comprehensive geriatric assessment and long-term follow-up are warranted.
Our findings support an inclusive approach to rehabilitation referral. Advanced age alone should not be used to restrict access to post-acute rehabilitation services. Even in a very advanced age, structured inpatient rehabilitation can facilitate functional improvement and successful reintegration into the community.

References

  1. Benjamin, E.J.; Blaha, M.J.; Chiuve, S.E.; Cushman, M.; Das, S.R.; Deo, R.; de Ferranti, S.D.; Floyd, J.; Fornage, M.; Gillespie, C.; et al. Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association. Circulation 2017, 135. [Google Scholar] [CrossRef]
  2. Wafa, H.A.; Wolfe, C.D.A.; Emmett, E.; Roth, G.A.; Johnson, C.O.; Wang, Y. Burden of Stroke in Europe: Thirty-Year Projections of Incidence, Prevalence, Deaths, and Disability-Adjusted Life Years. Stroke 2020, 51, 2418–2427. [Google Scholar] [CrossRef]
  3. Venketasubramanian, N.; Tan, L.C.S.; Sahadevan, S. Prevalence of stroke among Chinese, Malay, and Indian Singaporeans: A community-based tri-racial cross-sectional survey. Stroke 2005, 36, 551–556. [Google Scholar] [CrossRef] [PubMed]
  4. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study. Lancet 2016, 388, 1545–1602. [CrossRef] [PubMed]
  5. Denti, L.; Scoditti, U.; Tonelli, C.; Saccavini, M.; Caminiti, C.; Valcavi, R.; Benatti, M.; Ceda, G.P. The Poor Outcome of Ischemic Stroke in Very Old People: A Cohort Study of Its Determinants. J. Am. Geriatr. Soc. 2010, 58, 12–17. [Google Scholar] [CrossRef]
  6. Pohl, P.S.; Billinger, S.A.; Lentz, A.; Gajewski, B. The role of patient demographics and clinical presentation in predicting discharge placement after inpatient stroke rehabilitation: analysis of a large, US data base. Disabil. Rehabilitation 2012, 35, 990–994. [Google Scholar] [CrossRef] [PubMed]
  7. Mutai, H.; Furukawa, T.; Araki, K.; Misawa, K.; Hanihara, T. Factors associated with functional recovery and home discharge in stroke patients admitted to a convalescent rehabilitation ward. Geriatr. Gerontol. Int. 2011, 12, 215–222. [Google Scholar] [CrossRef]
  8. Saposnik, G.; Cote, R.; Phillips, S.; et al. Stroke outcome in those over 80: Amulticenter cohort study across Canada. Stroke 2008, 39, 2310–2317. [Google Scholar] [CrossRef]
  9. Gaynor, E.J.; Geoghegan, S.E.; O’neill, D. Ageism in stroke rehabilitation studies. Age and Ageing 2014, 43, 429–431. [Google Scholar] [CrossRef]
  10. Lieberman, D. Rehabilitation following stroke in patients aged 85 and above. J Rehabil Res Dev 2005, 42, 47–53. [Google Scholar]
  11. Arboix, A.; García-Eroles, L.; Massons, J.; Oliveres, M.; Targa, C. Acute Stroke in Very Old People: Clinical Features and Predictors of In-Hospital Mortality. J. Am. Geriatr. Soc. 2000, 48, 36–41. [Google Scholar] [CrossRef]
  12. Di Carlo, A.; Lamassa, M.; Pracucci, G. for the European BIOMED Study of Stroke Care Group. Stroke in the very old. Clinical presentation and determinants of 3-month functional outcome: A European perspective. Stroke 1999, 30, 2313–2319. [Google Scholar] [CrossRef]
  13. Luk, J.K.; Cheung, R.T.; Ho, S.; Li, L. Does Age Predict Outcome in Stroke Rehabilitation? A Study of 878 Chinese Subjects. Cerebrovasc. Dis. 2006, 21, 229–234. [Google Scholar] [CrossRef]
  14. Myint, P.K.; Vowler, S.L.; Redmayne, O.; Fulcher, R.A. Cognition, Continence and Transfer Status at the Time of Discharge from an Acute Hospital Setting and Their Associations with an Unfavourable Discharge Outcome after Stroke. Gerontology 2008, 54, 202–209. [Google Scholar] [CrossRef]
  15. Kammersgaard, L.P.; Jorgensen, H.S.; Reith, J.; Nakayama, H.; Pedersen, P.M.; Olsen, T.S. Short- and long-term prognosis for every old stroke patients. The Copenhagen Stroke Study. Age and Ageing. 2004, 33, 149–154. [Google Scholar] [CrossRef]
  16. Denti, L.; Agosti, M.; Franceschini, M. Outcome predictors of rehabilitation for first stroke in the elderly. Europ J Phys Rehab Med 2008, 44, 3–11. [Google Scholar]
  17. Nguyen, V.Q.C.; PrvuBettger, J.; Guerrier, T.; et al. Factors Associated With Discharge to Home Versus Discharge to Institutional Care After Inpatient Stroke Rehabilitation. Arch Phys Med Rehab 2015, 96, 1297–303. [Google Scholar] [CrossRef] [PubMed]
  18. Nguyen, T.-A.; Page, A.; Aggarwal, A.; Henke, P. Social Determinants of Discharge Destination for Patients After Stroke With Low Admission FIM Instrument Scores. Arch. Phys. Med. Rehabilitation 2007, 88, 740–744. [Google Scholar] [CrossRef]
  19. Administration for Community Living. 2023 Profile of Older Americans; U.S. Department of Health and Human Services, 2023.
  20. Office for National Statistics. Older people living in care homes in 2021 and changes since 2011; ONS: London, 2023. [Google Scholar]
  21. Statistics Canada. Living arrangements of seniors, 2011 Census; Statistics Canada: Ottawa, 2011. [Google Scholar]
  22. Wastesson, J.W.; Canudas-Romo, V.; Lindahl-Jacobsen, R.; Johnell, K. Remaining Life Expectancy With and Without Polypharmacy: A Register-Based Study of Swedes Aged 65 Years and Older. J. Am. Med Dir. Assoc. 2016, 17, 31–35. [Google Scholar] [CrossRef] [PubMed]
  23. Morin, L.; Johnell, K.; Laroche, M.-L.; Fastbom, J.; Wastesson, J.W. The epidemiology of polypharmacy in older adults: register-based prospective cohort study. Clin. Epidemiology 2018, 10, 289–298. [Google Scholar] [CrossRef]
  24. Bonanno, E.G.; Figueiredo, T.; Mimoso, I.F.; Morgado, M.I.; Carrilho, J.; Midão, L.; Costa, E. Polypharmacy Prevalence Among Older Adults Based on the Survey of Health, Ageing and Retirement in Europe: An Update. J. Clin. Med. 2025, 14, 1330. [Google Scholar] [CrossRef]
  25. Viktil, K.K.; Blix, H.S. The impact of polypharmacy on the risk of drug–drug interactions and potentially inappropriate medications in the elderly. Br J Clin Pharmacol. 2008, 67, 205–213. [Google Scholar]
  26. Berman, E.; Noyman, I.; Medvedovsky, M.; Ekstein, D.; Eyal, S. Not your usual drug-drug interactions: Monoclonal antibody–based therapeutics may interact with antiseizure medications. Epilepsia 2021, 63, 271–289. [Google Scholar] [CrossRef] [PubMed]
  27. Vocca, C.; Siniscalchi, A.; Rania, V.; Galati, C.; Marcianò, G.; Palleria, C.; Catarisano, L.; Gareri, I.; Leuzzi, M.; Muraca, L.; et al. The Risk of Drug Interactions in Older Primary Care Patients after Hospital Discharge: The Role of Drug Reconciliation. Geriatrics 2023, 8, 122. [Google Scholar] [CrossRef]
  28. Aggarwal, P.; Woolford, S.J.; Patel, H.P. Multi-Morbidity and Polypharmacy in Older People: Challenges and Opportunities for Clinical Practice. Geriatrics 2020, 5, 85. [Google Scholar] [CrossRef] [PubMed]
  29. Olfson, M.; King, M.; Schoenbaum, M. Antipsychotic Treatment of Adults in the United States. J. Clin. Psychiatry 2015, 76, 1346–1353. [Google Scholar] [CrossRef]
  30. Schieber, L.Z.; Guy, G.P.; Seth, P.; Losby, J.L. Variation in Adult Outpatient Opioid Prescription Dispensing by Age and Sex — United States, 2008–2018. Mmwr-Morbidity Mortal. Wkly. Rep. 2020, 69, 298–302. [Google Scholar] [CrossRef]
  31. Russo, A.; et al. Impact of new biological, genetic, immunotherapies, including monoclonal antibodies, in cancer management with age-related considerations. Med Crave Online J Geriatr Gerontol. 2025, 10, 00339. [Google Scholar]
  32. Viktil, K.K.; Blix, H.S. The impact of polypharmacy on the risk of drug–drug interactions and potentially inappropriate medications in the elderly. Br J Clin Pharmacol. 2008, 67, 205–213. [Google Scholar]
  33. Onder, G.; Pedone, C.; Landi, F.; Cesari, M.; Della Vedova, C.; Bernabei, R.; Gambassi, G. Adverse Drug Reactions as Cause of Hospital Admissions: Results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J. Am. Geriatr. Soc. 2002, 50, 1962–1968. [Google Scholar] [CrossRef]
  34. Sandstrom, R.; Mokler, P.J.; Hoppe, K.M. Discharge destination and motor function outcome in severe stroke as measured by the functional independence measure/function-related group classification system. Arch. Phys. Med. Rehabilitation 1998, 79, 762–765. [Google Scholar] [CrossRef] [PubMed]
Table 1. Characteristics of patients enrolled in the study (N=876).
Table 1. Characteristics of patients enrolled in the study (N=876).
Characteristic 65-89 years n=803 90 years and over n=73 P value
Age (median) 76 92 <0.001
Sex: female 453 (56.4%) 32 (43.8%) 0.038
Marital status (reference = married) 423 (52.7%) 18 (24.7%) <0.001
Comorbidities
Atrial fibrillation 210 (26.2%) 27 (37.0%) 0.047
Diabetes 454 (56.5%) 17 (23.3%) <0.001
Hypertension 671 (83.6%) 64 (87.7%) 0.360
Hyperlipidemia 452 (56.4%) 28 (38.4%) 0.003
IHD 217 (27.0%) 23 (31.5%) 0.411
CHF 117 (14.6%) 11 (15.1%) 0.912
CKD 140 (17.4%) 13 (17.8%) 0.936
Dementia 84 (10.5%) 15 (20.5%) 0.009
Constipation 363 (45.2%) 44 (60.3%) 0.013
Cognitive impairment 232 (29.0%) 31 (45.5%) 0.052
Smoking 148 (18.5%) 2 (2.7%) 0.001
No. of medications (median) 8 7 0.62
Characteristic 65-89 years n=803 90 years and over n=73 P value
Blood tests
Hb 12.4 12.35 0.566
Albumin 3.6 3.5 0.577
Creatinine 0.83 0.88 0.678
Cholesterol 155.8 161.7 0.645
Stroke type
hemorrhagic
(Vs ischemic)
140 (17.4%) 9 (12.3%) 0.266
Deficits
Aphasia 114 (14.2%) 13 (17.8%) 0.401
Dysarthria 262 (32.7%) 19 (26.4%) 0.274
Dysphagia 118 (14.7%) 11 (15.1%) 0.935
Right hemiparesis 297 (37.0%) 21 (28.8%) 0.162
Left hemiparesis 323 (40.3%) 35 (47.9%) 0.205
Table 2. Outcome and complications in octogenarian post stroke rehabilitation (N=876).
Table 2. Outcome and complications in octogenarian post stroke rehabilitation (N=876).
Characteristic 65-89 years n=803 90 years and over n=73 P value
Length of stay 41 40 0.93
Pneumonia 21 (2.6%) 4 (5.5%)
Urinary retention on admission 55 (6.8%) 9 (12.3%)
Catheter before admission 56 (7.0%) 10 (13.7%)
Catheter discharge 49 (6.1%) 10 (13.7%)
Constipation 363 (45.2%) 44 (60.3%) 0.013
Cognitive impairment
FIM admission 54 46 <0.001
FIM discharge 69.7 55.07 <0.001
Delta FIM 16 11 0.007
Discharge to the community 626 (78.2%) 56 (76.7%) 0.776
Discharge to the long-term care facility 56 (7.0%) 3 (4.1%)
Discharge to the general hospital 102 (12.8%) 10 (14.3%)
Table 3. Regression analysis of characteristics independently associated with discharge home (N=876).
Table 3. Regression analysis of characteristics independently associated with discharge home (N=876).
Characteristic Percent OR 95% CI P value
Married ----
Diabetes mellitus -----
Constipation -80.38
Atrial fibrillation -43.10
Aphasia -39.75
Pneumonia -64.09
Cognitive impairment intermediate ---
Catheter discharge -74.97
Delta FIM 6.72
Percent that is associated with increases or decreases of the chance of discharge to the community.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2026 MDPI (Basel, Switzerland) unless otherwise stated